{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:17:42Z","timestamp":1763036262683},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T00:00:00Z","timestamp":1190246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s00108-007-1934-6","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T12:00:18Z","timestamp":1190116818000},"page":"1101-1118","source":"Crossref","is-referenced-by-count":14,"title":["Metabolische Knochenerkrankungen"],"prefix":"10.1007","volume":"48","author":[{"given":"F.","family":"Jakob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,20]]},"reference":[{"key":"1934_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/dtb.2006.44425","volume":"44","author":"Anonymous","year":"2006","unstructured":"Anonymous (2006) Primary vitamin D deficiency in adults. Drug Ther Bull 44: 25\u201329","journal-title":"Drug Ther Bull"},{"key":"1934_CR2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4314\/eamj.v78i11.8945","volume":"78","author":"Akpede","year":"2001","unstructured":"Akpede GO, Solomon EA, Jalo I et al. (2001) Nutritional rickets in young Nigerian children in the Sahel savanna. East Afr Med J 78: 568\u2013575","journal-title":"East Afr Med J"},{"key":"1934_CR3","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.surg.2004.06.059","volume":"136","author":"Almqvist","year":"2004","unstructured":"Almqvist EG, Becker C, Bondeson AG et al. (2004) Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study. Surgery 136: 1281\u20131288","journal-title":"Surgery"},{"key":"1934_CR4","first-page":"58","volume":"Endocrinol","author":"Almqvist","year":"2006","unstructured":"Almqvist EG, Becker C, Bondeson AG et al. (2006) Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyperparathyroidism in postmenopausal women. Clin Endocrinol (Oxf) 64: 58\u201362","journal-title":"Clin"},{"key":"1934_CR5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00198-005-1920-6","volume":"17","author":"Angelopoulos","year":"2006","unstructured":"Angelopoulos NG, Goula AK, Papanikolaou G, Tolis G (2006) Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature. Osteoporos Int 17: 150\u2013155","journal-title":"Osteoporos Int"},{"key":"1934_CR6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jc.2006-1788","volume":"92","author":"Antoniucci","year":"2007","unstructured":"Antoniucci DM, Sellmeyer DE, Bilezikian JP et al. (2007) Elevations in serum and urinary calcium with parathyroid hormone (1\u201384) with and without alendronate for osteoporosis. J Clin Endocrinol Metab 92: 942\u2013947","journal-title":"J Clin Endocrinol Metab"},{"key":"1934_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"Benet-Pages","year":"2005","unstructured":"Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14: 385\u2013390","journal-title":"Hum Mol Genet"},{"key":"1934_CR8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11914-996-0031-4","volume":"4","author":"Bernstein","year":"2006","unstructured":"Bernstein CN (2006) Inflammatory bowel diseases as secondary causes of osteoporosis. Curr Osteoporos Rep 4: 116\u2013123","journal-title":"Curr Osteoporos Rep"},{"key":"1934_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11914-006-0009-2","volume":"4","author":"Bilezikian","year":"2006","unstructured":"Bilezikian JP, Rubin MR (2006) Combination\/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis. Curr Osteoporos Rep 4: 5\u201313","journal-title":"Curr Osteoporos Rep"},{"key":"1934_CR10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11914-996-0018-1","volume":"3","author":"Binkley","year":"2005","unstructured":"Binkley N, Krueger D (2005) Combination therapy for osteoporosis: considerations and controversy. Curr Osteoporos Rep 3: 150\u2013154","journal-title":"Curr Osteoporos Rep"},{"key":"1934_CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S8756-3282(00)00272-6","volume":"26","author":"Bjarnason","year":"2000","unstructured":"Bjarnason NH, Christiansen C (2000) Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone 26: 561\u2013569","journal-title":"Bone"},{"key":"1934_CR12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","volume":"353","author":"Black","year":"2005","unstructured":"Black DM, Bilezikian JP, Ensrud KE et al. (2005) One year of alendronate after one year of parathyroid hormone (1\u201384) for osteoporosis. N Engl J Med 353: 555\u2013565","journal-title":"N Engl J Med"},{"key":"1934_CR13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.biocel.2006.11.008","volume":"39","author":"Blair","year":"2007","unstructured":"Blair JM, Zheng Y, Dunstan CR (2007) RANK ligand. Int J Biochem Cell Biol 39: 1077\u20131081","journal-title":"Int J Biochem Cell Biol"},{"key":"1934_CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ncponc0381","volume":"3","author":"Blair","year":"2006","unstructured":"Blair JM, Zhou H, Seibel MJ, Dunstan CR (2006) Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat Clin Pract Oncol 3: 41\u201349","journal-title":"Nat Clin Pract Oncol"},{"key":"1934_CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00223-005-0009-8","volume":"78","author":"Boonen","year":"2006","unstructured":"Boonen S, Bischoff-Ferrari HA, Cooper C et al. (2006) Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int 78: 257\u2013270","journal-title":"Calcif Tissue Int"},{"key":"1934_CR16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2796.2006.01655.x","volume":"259","author":"Boonen","year":"2006","unstructured":"Boonen S, Vanderschueren D, Haentjens P, Lips P (2006) Calcium and vitamin D in the prevention and treatment of osteoporosis \u2013 a clinical update. J Intern Med 259: 539\u2013552","journal-title":"J Intern Med"},{"key":"1934_CR17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.healun.2006.11.004","volume":"26","author":"Braith","year":"2007","unstructured":"Braith RW, Conner JA, Fulton MN et al. (2007) Comparison of alendronate vs alendronate plus mechanical loading as prophylaxis for osteoporosis in lung transplant recipients: a pilot study. J Heart Lung Transplant 26: 132\u2013137","journal-title":"J Heart Lung Transplant"},{"key":"1934_CR18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S1053-2498(02)01184-1","volume":"22","author":"Braith","year":"2003","unstructured":"Braith RW, Magyari PM, Fulton MN et al. (2003) Resistance exercise training and alendronate reverse glucocorticoid-induced osteoporosis in heart transplant recipients. J Heart Lung Transplant 22: 1082\u20131090","journal-title":"J Heart Lung Transplant"},{"key":"1934_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s003930170084","volume":"60","author":"Braun","year":"2001","unstructured":"Braun J (2001) Epidemiology of corticosteroid-induced osteoporosis. Z Rheumatol 60: 107\u2013110","journal-title":"Z Rheumatol"},{"key":"1934_CR20","first-page":"S97","volume":"Nutr","author":"Brot","year":"2001","unstructured":"Brot C, Vestergaard P, Kolthoff N et al. (2001) Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr (Suppl 1) 86: S97\u2013S103","journal-title":"Br J"},{"key":"1934_CR21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ncpendmet0394","volume":"3","author":"Brown","year":"2007","unstructured":"Brown AJ, Slatopolsky E (2007) Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Nat Clin Pract Endocrinol Metab 3: 134\u2013144","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1934_CR22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1079\/PHN2003536","volume":"7","author":"Brustad","year":"2004","unstructured":"Brustad M, Alsaker E, Engelsen O et al. (2004) Vitamin D status of middle-aged women at 65\u201371 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 7: 327\u2013335","journal-title":"Public Health Nutr"},{"key":"1934_CR23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1079\/PHN2004605","volume":"7","author":"Brustad","year":"2004","unstructured":"Brustad M, Sandanger T, Aksnes L, Lund E (2004) Vitamin D status in a rural population of northern Norway with high fish liver consumption. Public Health Nutr 7: 783\u2013789","journal-title":"Public Health Nutr"},{"key":"1934_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/187153006776056666","volume":"6","author":"Carter","year":"2006","unstructured":"Carter PH, Schipani E (2006) The roles of parathyroid hormone and calcitonin in bone remodeling: prospects for novel therapeutics. Endocr Metab Immune Disord Drug Targets 6: 59\u201376","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1934_CR25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jc.2003-030501","volume":"89","author":"Clowes","year":"2004","unstructured":"Clowes JA, Peel NF, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89: 1117\u20131123","journal-title":"J Clin Endocrinol Metab"},{"key":"1934_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000050944","volume":"67","author":"Coen","year":"2001","unstructured":"Coen G, Sardella D, Barbera G et al. (2001) Urinary composition and lithogenic risk in normal subjects following oligomineral versus bicarbonate-alkaline high calcium mineral water intake. Urol Int 67: 49\u201353","journal-title":"Urol Int"},{"key":"1934_CR27","first-page":"566","volume":"19","author":"Cozzolino","year":"2006","unstructured":"Cozzolino M, Gallieni M, Brancaccio D et al. (2006) Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. J Nephrol 19: 566\u2013577","journal-title":"J Nephrol"},{"key":"1934_CR28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.micron.2005.07.007","volume":"36","author":"Dalle","year":"2005","unstructured":"Dalle Carbonare L, Valenti MT, Bertoldo F et al. (2005) Bone microarchitecture evaluated by histomorphometry. Micron 36: 609\u2013616","journal-title":"Micron"},{"key":"1934_CR29","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1359\/jbmr.2000.15.11.2169","volume":"15","author":"Damien","year":"2000","unstructured":"Damien E, Price JS, Lanyon LE (2000) Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females. J Bone Miner Res 15: 2169\u20132177","journal-title":"J Bone Miner Res"},{"key":"1934_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000441-200502000-00001","volume":"329","author":"De","year":"2005","unstructured":"De Prisco C, Levine SN (2005) Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci 329: 57\u201361","journal-title":"Am J Med Sci"},{"key":"1934_CR31","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/JBMR.050714","volume":"20","author":"Deal","year":"2005","unstructured":"Deal C, Omizo M, Schwartz EN et al. (2005) Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial. J Bone Miner Res 20: 1905\u20131911","journal-title":"J Bone Miner Res"},{"key":"1934_CR32","first-page":"86","volume":"1","author":"Delling","year":"1980","unstructured":"Delling G (1980) Diagnosis of generalized osteopathies\u2013methodological considerations and diagnostic possibilities. Pathologe 1: 86\u201392","journal-title":"Pathologe"},{"key":"1934_CR33","first-page":"555","volume":"26","author":"Delling","year":"1986","unstructured":"Delling G, Dreyer T (1986) The morphology of generalized osteopathies. Radiologe 26: 555\u2013562","journal-title":"Radiologe"},{"key":"1934_CR34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1359\/JBMR.041214","volume":"20","author":"Delmas","year":"2005","unstructured":"Delmas PD, Langerijt L van de, Watts NB et al. (2005) Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study. J Bone Miner Res 20: 557\u2013563","journal-title":"J Bone Miner Res"},{"key":"1934_CR35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1196\/annals.1346.026","volume":"1068","author":"Demay","year":"2006","unstructured":"Demay MB (2006) Mechanism of vitamin D receptor action. Ann N Y Acad Sci 1068: 204\u2013213","journal-title":"Ann N Y Acad Sci"},{"key":"1934_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00198-005-2032-z","volume":"17","author":"Devogelaer","year":"2006","unstructured":"Devogelaer JP, Goemaere S, Boonen S et al. (2006) Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int 17: 8\u201319","journal-title":"Osteoporos Int"},{"key":"1934_CR37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ncponc0688","volume":"4","author":"Dunstan","year":"2007","unstructured":"Dunstan CR, Felsenberg D, Seibel MJ (2007) Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol 4: 42\u201355","journal-title":"Nat Clin Pract Oncol"},{"key":"1934_CR38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","volume":"36","author":"Dupond","year":"2005","unstructured":"Dupond JL, Mahammedi H, Prie D et al. (2005) Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET\/CT scan for the diagnosis and follow-up in one case. Bone 36: 375\u2013378","journal-title":"Bone"},{"key":"1934_CR39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jocd.2006.06.002","volume":"9","author":"Durosier","year":"2006","unstructured":"Durosier C, Hans D, Krieg MA, Schott AM (2006) Prediction and discrimination of osteoporotic hip fracture in postmenopausal women. J Clin Densitom 9: 475\u2013495","journal-title":"J Clin Densitom"},{"key":"1934_CR40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1359\/JBMR.050217","volume":"20","author":"Eastell","year":"2005","unstructured":"Eastell R, Delmas PD (2005) How to interpret surrogate markers of efficacy in osteoporosis. J Bone Miner Res 20: 1261\u20131262; author reply 1263\u20131264","journal-title":"J Bone Miner Res"},{"key":"1934_CR41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2005.11.039","volume":"248","author":"Ebert","year":"2006","unstructured":"Ebert R, Schutze N, Adamski J, Jakob F (2006) Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol 248: 149\u2013159","journal-title":"Mol Cell Endocrinol"},{"key":"1934_CR42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bone.2005.08.024","volume":"38","author":"Egan","year":"2006","unstructured":"Egan E, Reilly T, Giacomoni M et al. (2006) Bone mineral density among female sports participants. Bone 38: 227\u2013233","journal-title":"Bone"},{"key":"1934_CR43","first-page":"167","volume":"50","author":"El-Maghraby","year":"2006","unstructured":"El-Maghraby TA, Moustafa HM, Pauwels EK (2006) Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities. Q J Nucl Med Mol Imaging 50: 167\u2013192","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1934_CR44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bone.2006.07.027","volume":"40","author":"Elston","year":"2007","unstructured":"Elston MS, Stewart IJ, Clifton-Bligh R, Conaglen JV (2007) A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: Description of the biochemical response of FGF23 to octreotide therapy and surgery. Bone 40: 236\u2013241","journal-title":"Bone"},{"key":"1934_CR45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2458-6-87","volume":"6","author":"Endres","year":"2006","unstructured":"Endres HG, Dasch B, Lungenhausen M et al. (2006) Patients with femoral or distal forearm fracture in Germany: a prospective observational study on health care situation and outcome. BMC Public Health 6: 87","journal-title":"BMC Public Health"},{"key":"1934_CR46","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00198-005-0039-0","volume":"17","author":"Engelke","year":"2006","unstructured":"Engelke K, Gluer CC (2006) Quality and performance measures in bone densitometry: part 1: errors and diagnosis. Osteoporos Int 17: 1283\u20131292","journal-title":"Osteoporos Int"},{"key":"1934_CR47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00198-005-1938-9","volume":"17","author":"Engelke","year":"2006","unstructured":"Engelke K, Kemmler W, Lauber D et al. (2006) Exercise maintains bone density at spine and hip EFOPS: a 3-year longitudinal study in early postmenopausal women. Osteoporos Int 17: 133\u2013142","journal-title":"Osteoporos Int"},{"key":"1934_CR48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clinthera.2006.02.007","volume":"28","author":"Epstein","year":"2006","unstructured":"Epstein S (2006) Update of current therapeutic options for the treatment of postmenopausal osteoporosis. Clin Ther 28: 151\u2013173","journal-title":"Clin Ther"},{"key":"1934_CR49","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00198-006-0069-2","volume":"17","author":"Erkal","year":"2006","unstructured":"Erkal MZ, Wilde J, Bilgin Y et al. (2006) High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int 17: 1133\u20131140","journal-title":"Osteoporos Int"},{"key":"1934_CR50","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ncpendmet0348","volume":"2","author":"Felsenberg","year":"2006","unstructured":"Felsenberg D (2006) Osteonecrosis of the jaw\u2013a potential adverse effect of bisphosphonate treatment. Nat Clin Pract Endocrinol Metab 2: 662\u2013663","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1934_CR51","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00198-005-1880-x","volume":"16","author":"Ferrar","year":"2005","unstructured":"Ferrar L, Jiang G, Adams J, Eastell R (2005) Identification of vertebral fractures: an update. Osteoporos Int 16: 717\u2013728","journal-title":"Osteoporos Int"},{"key":"1934_CR52","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","volume":"349","author":"Finkelstein","year":"2003","unstructured":"Finkelstein JS, Hayes A, Hunzelman JL et al. (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349: 1216\u20131226","journal-title":"N Engl J Med"},{"key":"1934_CR53","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1210\/jc.2006-0190","volume":"91","author":"Finkelstein","year":"2006","unstructured":"Finkelstein JS, Leder BZ, Burnett SM et al. (2006) Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men. J Clin Endocrinol Metab 91: 2882\u20132887","journal-title":"J Clin Endocrinol Metab"},{"key":"1934_CR54","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1359\/jbmr.2000.15.11.2206","volume":"15","author":"Fischer","year":"2000","unstructured":"Fischer PR, Thacher TD, Pettifor JM et al. (2000) Vitamin D receptor polymorphisms and nutritional rickets in Nigerian children. J Bone Miner Res 15: 2206\u20132210","journal-title":"J Bone Miner Res"},{"key":"1934_CR55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.mco.0000196140.95916.3a","volume":"9","author":"Francis","year":"2006","unstructured":"Francis RM (2006) Calcium, vitamin D and involutional osteoporosis. Curr Opin Clin Nutr Metab Care 9: 13\u201317","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1934_CR56","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/jc.2004-1350","volume":"90","author":"Frassetto","year":"2005","unstructured":"Frassetto L, Morris RC Jr, Sebastian A (2005) Long-term persistence of the urine calcium-lowering effect of potassium bicarbonate in postmenopausal women. J Clin Endocrinol Metab 90: 831\u2013834","journal-title":"J Clin Endocrinol Metab"},{"key":"1934_CR57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00198-006-0199-6","volume":"18","author":"Genant","year":"2007","unstructured":"Genant HK, Delmas PD, Chen P et al. (2007) Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int 18: 69\u201376","journal-title":"Osteoporos Int"},{"key":"1934_CR58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1196\/annals.1346.038","volume":"1068","author":"Genant","year":"2006","unstructured":"Genant HK, Jiang Y (2006) Advanced imaging assessment of bone quality. Ann N Y Acad Sci 1068: 410\u2013428","journal-title":"Ann N Y Acad Sci"},{"key":"1934_CR59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bone.2006.07.014","volume":"40","author":"Gluer","year":"2007","unstructured":"Gluer CC (2007) Quantitative Ultrasound-It is time to focus research efforts. Bone 40: 9\u201313","journal-title":"Bone"},{"key":"1934_CR60","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00198-005-0038-1","volume":"17","author":"Gluer","year":"2006","unstructured":"Gluer CC, Lu Y, Engelke K (2006) Quality and performance measures in bone densitometry. Part 2: fracture risk. Osteoporos Int 17: 1449\u20131458","journal-title":"Osteoporos Int"},{"key":"1934_CR61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00774-005-0664-x","volume":"24","author":"Goodman","year":"2006","unstructured":"Goodman WG (2006) Renal osteodystrophy for nonnephrologists. J Bone Miner Metab 24: 161\u2013163","journal-title":"J Bone Miner Metab"},{"key":"1934_CR62","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/ajcn\/80.5.1415","volume":"80","author":"Graff","year":"2004","unstructured":"Graff M, Thacher TD, Fischer PR et al. (2004) Calcium absorption in Nigerian children with rickets. Am J Clin Nutr 80: 1415\u20131421","journal-title":"Am J Clin Nutr"},{"key":"1934_CR63","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00198-004-1732-0","volume":"16","author":"Grahn","year":"2005","unstructured":"Grahn Kronhed AC, Blomberg C, Karlsson N et al. (2005) Impact of a community-based osteoporosis and fall prevention program on fracture incidence. Osteoporos Int 16: 700\u2013706","journal-title":"Osteoporos Int"},{"key":"1934_CR64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2796.2005.01600.x","volume":"259","author":"Hagstrom","year":"2006","unstructured":"Hagstrom E, Lundgren E, Mallmin H et al. (2006) Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. J Intern Med 259: 191\u2013198","journal-title":"J Intern Med"},{"key":"1934_CR65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0305-7372(06)80003-4","volume":"Rev","author":"Hannon","year":"2006","unstructured":"Hannon RA, Eastell R (2006) Bone markers and current laboratory assays. Cancer Treat Rev (Suppl 1) 32: 7\u201314","journal-title":"Cancer Treat"},{"key":"1934_CR66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00198-006-0206-y","volume":"18","author":"Haussler","year":"2007","unstructured":"Haussler B, Gothe H, Gol D et al. (2007) Epidemiology, treatment and costs of osteoporosis in Germany-the BoneEVA Study. Osteoporos Int 18: 77\u201384","journal-title":"Osteoporos Int"},{"key":"1934_CR67","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1359\/jbmr.060909","volume":"22","author":"Hesse","year":"2007","unstructured":"Hesse E, Moessinger E, Rosenthal H et al. (2007) Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography. J Bone Miner Res 22: 158\u2013162","journal-title":"J Bone Miner Res"},{"key":"1934_CR68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00198-006-0282-z","volume":"18","author":"Hofbauer","year":"2007","unstructured":"Hofbauer LC, Brueck CC, Shanahan CM et al. (2007) Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos Int 18: 251\u2013259","journal-title":"Osteoporos Int"},{"key":"1934_CR69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4065\/81.3.353","volume":"81","author":"Holick","year":"2006","unstructured":"Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81: 353\u2013373","journal-title":"Mayo Clin Proc"},{"key":"1934_CR70","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI29449","volume":"116","author":"Holick","year":"2006","unstructured":"Holick MF (2006) Resurrection of vitamin D deficiency and rickets. J Clin Invest 116: 2062\u20132072","journal-title":"J Clin Invest"},{"key":"1934_CR71","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11914-996-0028-z","volume":"4","author":"Holick","year":"2006","unstructured":"Holick MF (2006) The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep 4: 96\u2013102","journal-title":"Curr Osteoporos Rep"},{"key":"1934_CR72","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/j.semnuclmed.2006.05.001","volume":"36","author":"Horger","year":"2006","unstructured":"Horger M, Bares R (2006) The role of single-photon emission computed tomography\/computed tomography in benign and malignant bone disease. Semin Nucl Med 36: 286\u2013294","journal-title":"Semin Nucl Med"},{"key":"1934_CR73","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-2005-872469","volume":"143","author":"Hube","year":"2005","unstructured":"Hube R, Kafer W, Klima S et al. (2005) Osteoporosis\u2013a neglected issue in orthopaedics? Results of a survey amongst German orthopaedic surgeons. Z Orthop Ihre Grenzgeb 143: 520\u2013528","journal-title":"Z Orthop Ihre Grenzgeb"},{"key":"1934_CR74","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1210\/jc.2003-032016","volume":"89","author":"Ince","year":"2004","unstructured":"Ince BA, Anderson EJ, Neer RM (2004) Lowering dietary protein to U.S. Recommended dietary allowance levels reduces urinary calcium excretion and bone resorption in young women. J Clin Endocrinol Metab 89: 3801\u20133807","journal-title":"J Clin Endocrinol Metab"},{"key":"1934_CR75","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","volume":"354","author":"Jackson","year":"2006","unstructured":"Jackson RD, LaCroix AZ, Gass M et al. (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354: 669\u2013683","journal-title":"N Engl J Med"},{"key":"1934_CR76","doi-asserted-by":"crossref","unstructured":"Jakob F (1999) 1,25(OH)2-vitamin D3. The vitamin D hormone. Internist (Berl) 40: W414\u2013W430","DOI":"10.1007\/s001080050353"},{"key":"1934_CR77","doi-asserted-by":"crossref","unstructured":"Jakob F (2005) Primary and secondary osteoporosis. The important role of internal medicine in its differential diagnosis. Internist (Berl) (Suppl 1) 46: S24\u2013S30","DOI":"10.1007\/s00108-005-1417-6"},{"key":"1934_CR78","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1359\/jbmr.2004.19.6.938","volume":"19","author":"Jessop","year":"2004","unstructured":"Jessop HL, Suswillo RF, Rawlinson SC et al. (2004) Osteoblast-like cells from estrogen receptor alpha knockout mice have deficient responses to mechanical strain. J Bone Miner Res 19: 938\u2013946","journal-title":"J Bone Miner Res"},{"key":"1934_CR79","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"Johnell","year":"2006","unstructured":"Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17: 1726\u20131733","journal-title":"Osteoporos Int"},{"key":"1934_CR80","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2005-837390","volume":"130","author":"Kann","year":"2005","unstructured":"Kann PH (2005) Secondary osteoporosis in endocrine diseases. Dtsch Med Wochenschr 130: 165\u2013170","journal-title":"Dtsch Med Wochenschr"},{"key":"1934_CR81","first-page":"63","volume":"6","author":"Katz","year":"2006","unstructured":"Katz S (2006) Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment. Rev Gastroenterol Disord 6: 63\u201371","journal-title":"Rev Gastroenterol Disord"},{"key":"1934_CR82","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.0601643103","volume":"103","author":"Kavanagh","year":"2006","unstructured":"Kavanagh KL, Guo K, Dunford JE et al. (2006) The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc Natl Acad Sci U S A 103: 7829\u20137834","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1934_CR83","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.berh.2005.06.005","volume":"19","author":"Kelman","year":"2005","unstructured":"Kelman A, Lane NE (2005) The management of secondary osteoporosis. Best Pract Res Clin Rheumatol 19: 1021\u20131037","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1934_CR84","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/00005768-200212000-00038","volume":"34","author":"Kemmler","year":"2002","unstructured":"Kemmler W, Engelke K, Lauber D et al. (2002) Exercise effects on fitness and bone mineral density in early postmenopausal women: 1-year EFOPS results. Med Sci Sports Exerc 34: 2115\u20132123","journal-title":"Med Sci Sports Exerc"},{"key":"1934_CR85","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archinte.164.10.1084","volume":"164","author":"Kemmler","year":"2004","unstructured":"Kemmler W, Lauber D, Weineck J et al. (2004) Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women: results of the Erlangen Fitness Osteoporosis Prevention Study (EFOPS). Arch Intern Med 164: 1084\u20131091","journal-title":"Arch Intern Med"},{"key":"1934_CR86","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1055\/s-2005-872828","volume":"27","author":"Kemmler","year":"2006","unstructured":"Kemmler W, Roloff I, Baumann H et al. (2006) Effect of exercise, body composition, and nutritional intake on bone parameters in male elite rock climbers. Int J Sports Med 27: 653\u2013659","journal-title":"Int J Sports Med"},{"key":"1934_CR87","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11914-006-0013-6","volume":"4","author":"Kendler","year":"2006","unstructured":"Kendler DL (2006) Strontium ranelate\u2013data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action. Curr Osteoporos Rep 4: 34\u201339","journal-title":"Curr Osteoporos Rep"},{"key":"1934_CR88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02985616","volume":"18","author":"Kimizuka","year":"2004","unstructured":"Kimizuka T, Ozaki Y, Sumi Y (2004) Usefulness of 201Tl and 99mTc MIBI scintigraphy in a case of oncogenic osteomalacia. Ann Nucl Med 18: 63\u201367","journal-title":"Ann Nucl Med"},{"key":"1934_CR89","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0149-2918(00)86745-4","volume":"21","author":"Krappweis","year":"1999","unstructured":"Krappweis J, Rentsch A, Schwarz UI et al. (1999) Outpatient costs of osteoporosis in a national health insurance population. Clin Ther 21: 2001\u20132014","journal-title":"Clin Ther"},{"key":"1934_CR90","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/0003-4819-133-7-200010030-00010","volume":"133","author":"LaCroix","year":"2000","unstructured":"LaCroix AZ, Ott SM, Ichikawa L et al. (2000) Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 133: 516\u2013526","journal-title":"Ann Intern Med"},{"key":"1934_CR91","unstructured":"Laing CM, Unwin RJ (2006) Renal tubular acidosis. J Nephrol (Suppl 9) 19: S46\u2013S52"},{"key":"1934_CR92","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","volume":"194","author":"Lane","year":"2006","unstructured":"Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194: S3\u2013S11","journal-title":"Am J Obstet Gynecol"},{"key":"1934_CR93","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jbspin.2004.07.013","volume":"72","author":"Laroche","year":"2005","unstructured":"Laroche M, Boyer JF (2005) Phosphate diabetes, tubular phosphate reabsorption and phosphatonins. Joint Bone Spine 72: 376\u2013381","journal-title":"Joint Bone Spine"},{"key":"1934_CR94","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1074\/jbc.M509205200","volume":"281","author":"Lau","year":"2006","unstructured":"Lau KH, Kapur S, Kesavan C, Baylink DJ (2006) Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL\/6\u00a0J osteoblasts as opposed to C3H\/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J Biol Chem 281: 9576\u20139588","journal-title":"J Biol Chem"},{"key":"1934_CR95","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14712598.6.10.1041","volume":"6","author":"Lewiecki","year":"2006","unstructured":"Lewiecki EM (2006) RANK ligand inhibition with denosumab for the management of osteoporosis. Expert Opin Biol Ther 6: 1041\u20131050","journal-title":"Expert Opin Biol Ther"},{"key":"1934_CR96","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/en.2002-220821","volume":"144","author":"Li","year":"2003","unstructured":"Li J, Duncan RL, Burr DB et al. (2003) Parathyroid hormone enhances mechanically induced bone formation, possibly involving L-type voltage-sensitive calcium channels. Endocrinology 144: 1226\u20131233","journal-title":"Endocrinology"},{"key":"1934_CR97","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbrc.2006.02.063","volume":"342","author":"Liedert","year":"2006","unstructured":"Liedert A, Kaspar D, Claes L, Ignatius A (2006) Signal transduction pathways involved in mechanical regulation of HB-GAM expression in osteoblastic cells. Biochem Biophys Res Commun 342: 1070\u20131076","journal-title":"Biochem Biophys Res Commun"},{"key":"1934_CR98","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00330-005-2773-2","volume":"15","author":"Link","year":"2005","unstructured":"Link TM, Guglielmi G, Kuijk C van, Adams JE (2005) Radiologic assessment of osteoporotic vertebral fractures: diagnostic and prognostic implications. Eur Radiol 15: 1521\u20131532","journal-title":"Eur Radiol"},{"key":"1934_CR99","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"Lips","year":"2001","unstructured":"Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22: 477\u2013501","journal-title":"Endocr Rev"},{"key":"1934_CR100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pbiomolbio.2006.02.016","volume":"92","author":"Lips","year":"2006","unstructured":"Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92: 4\u20138","journal-title":"Prog Biophys Mol Biol"},{"key":"1934_CR101","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2796.2006.01685.x","volume":"260","author":"Lips","year":"2006","unstructured":"Lips P, Hosking D, Lippuner K et al. (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260: 245\u2013254","journal-title":"J Intern Med"},{"key":"1934_CR102","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/beem.2000.0073","volume":"14","author":"Lips","year":"2000","unstructured":"Lips P, Ooms ME (2000) Non-pharmacological interventions. Baillieres Best Pract Res Clin Endocrinol Metab 14: 265\u2013277","journal-title":"Baillieres Best Pract Res Clin Endocrinol Metab"},{"key":"1934_CR103","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1532-5415.2005.53525.x","volume":"53","author":"Liu-Ambrose","year":"2005","unstructured":"Liu-Ambrose TY, Khan KM, Eng JJ et al. (2005) The beneficial effects of group-based exercises on fall risk profile and physical activity persist 1\u00a0year postintervention in older women with low bone mass: follow-up after withdrawal of exercise. J Am Geriatr Soc 53: 1767\u20131773","journal-title":"J Am Geriatr Soc"},{"key":"1934_CR104","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00198-005-1942-0","volume":"17","author":"Lock","year":"2006","unstructured":"Lock CA, Lecouturier J, Mason JM, Dickinson HO (2006) Lifestyle interventions to prevent osteoporotic fractures: a systematic review. Osteoporos Int 17: 20\u201328","journal-title":"Osteoporos Int"},{"key":"1934_CR105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1258\/RSMSMJ.51.2.32","volume":"51","author":"Lowdon","year":"2006","unstructured":"Lowdon DW, Quinn C, Mole P, Leese GP (2006) Osteoporosis assessment and treatment in older patients who have sustained a hip fracture. Scott Med J 51: 32\u201335","journal-title":"Scott Med J"},{"key":"1934_CR106","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00774-005-0666-8","volume":"24","author":"Lund","year":"2006","unstructured":"Lund RJ, Davies MR, Mathew S, Hruska KA (2006) New discoveries in the pathogenesis of renal osteodystrophy. J Bone Miner Metab 24: 169\u2013171","journal-title":"J Bone Miner Metab"},{"key":"1934_CR107","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.165.8.905","volume":"165","author":"Majumdar","year":"2005","unstructured":"Majumdar SR, Kim N, Colman I et al. (2005) Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients. Arch Intern Med 165: 905\u2013909","journal-title":"Arch Intern Med"},{"key":"1934_CR108","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.bone.2005.07.029","volume":"38","author":"Marie","year":"2006","unstructured":"Marie PJ (2006) Strontium ranelate: a physiological approach for optimizing bone formation and resorption. Bone 38: S10\u2013S14","journal-title":"Bone"},{"key":"1934_CR109","first-page":"41","volume":"Klin","author":"Matthis","year":"1998","unstructured":"Matthis C, Raspe H (1998) Burden of illness in vertebral deformities. EVOS group in Germany. Med Klin (Suppl 2) 93: 41\u201346","journal-title":"Med"},{"key":"1934_CR110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tem.2006.03.009","volume":"17","author":"Mazziotti","year":"2006","unstructured":"Mazziotti G, Angeli A, Bilezikian JP et al. (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 17: 144\u2013149","journal-title":"Trends Endocrinol Metab"},{"key":"1934_CR111","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11926-005-0009-8","volume":"7","author":"Miller","year":"2005","unstructured":"Miller PD (2005) Treatment of metabolic bone disease in patients with chronic renal disease: a perspective for rheumatologists. Curr Rheumatol Rep 7: 53\u201360","journal-title":"Curr Rheumatol Rep"},{"key":"1934_CR112","first-page":"24","volume":"61","author":"Miller","year":"2006","unstructured":"Miller RG (2006) Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture. Geriatrics 61: 24\u201330","journal-title":"Geriatrics"},{"key":"1934_CR113","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J et al. (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69: 1945\u20131953","journal-title":"Kidney Int"},{"key":"1934_CR114","first-page":"29","volume":"167","author":"Mosekilde","year":"2005","unstructured":"Mosekilde L, Nielsen LR, Larsen ER et al. (2005) Vitamin D deficiency. Definition and prevalence in Denmark. Ugeskr Laeger 167: 29\u201333","journal-title":"Ugeskr Laeger"},{"key":"1934_CR115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","volume":"38","author":"Nancollas","year":"2006","unstructured":"Nancollas GH, Tang R, Phipps RJ et al. (2006) Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 38: 617\u2013627","journal-title":"Bone"},{"key":"1934_CR116","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1359\/JBMR.050903","volume":"21","author":"Nguyen","year":"2006","unstructured":"Nguyen ND, Eisman JA, Nguyen TV (2006) Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials. J Bone Miner Res 21: 340\u2013349","journal-title":"J Bone Miner Res"},{"key":"1934_CR117","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1359\/JBMR.050520","volume":"20","author":"Nguyen","year":"2005","unstructured":"Nguyen ND, Pongchaiyakul C, Center JR et al. (2005) Identification of high-risk individuals for hip fracture: a 14-year prospective study. J Bone Miner Res 20: 1921\u20131928","journal-title":"J Bone Miner Res"},{"key":"1934_CR118","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00268-004-7274-y","volume":"28","author":"Nordenstrom","year":"2004","unstructured":"Nordenstrom E, Westerdahl J, Bergenfelz A (2004) Recovery of bone mineral density in 126 patients after surgery for primary hyperparathyroidism. World J Surg 28: 502\u2013507","journal-title":"World J Surg"},{"key":"1934_CR119","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4158\/EP.12.4.436","volume":"12","author":"Painter","year":"2006","unstructured":"Painter SE, Kleerekoper M, Camacho PM (2006) Secondary osteoporosis: a review of the recent evidence. Endocr Pract 12: 436\u2013445","journal-title":"Endocr Pract"},{"key":"1934_CR120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1089\/aid.2006.22.1131","volume":"22","author":"Pan","year":"2006","unstructured":"Pan G, Kilby M, McDonald JM (2006) Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors. AIDS Res Hum Retroviruses 22: 1131\u20131141","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1934_CR121","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1196\/annals.1346.057","volume":"1068","author":"Pan","year":"2006","unstructured":"Pan G, Yang Z, Ballinger SW, McDonald JM (2006) Pathogenesis of osteopenia\/osteoporosis induced by highly active anti-retroviral therapy for AIDS. Ann N Y Acad Sci 1068: 297\u2013308","journal-title":"Ann N Y Acad Sci"},{"key":"1934_CR122","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1258\/095646206778145640","volume":"17","author":"Panayotakopoulos","year":"2006","unstructured":"Panayotakopoulos GD, Day S, Peters BS, Kulasegaram R (2006) Severe osteoporosis and multiple fractures in an AIDS patient treated with short-term steroids for lymphoma: a need for guidelines. Int J STD AIDS 17: 567\u2013568","journal-title":"Int J STD AIDS"},{"key":"1934_CR123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ageing\/afh238","volume":"34","author":"Patel","year":"2005","unstructured":"Patel S, Tweed K, Chinappen U (2005) Fall-related risk factors and osteoporosis in older women referred to an open access bone densitometry service. Age Ageing 34: 67\u201371","journal-title":"Age Ageing"},{"key":"1934_CR124","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ageing\/afl056","volume":"35","author":"Peel","year":"2006","unstructured":"Peel NM, McClure RJ, Hendrikz JK (2006) Health-protective behaviours and risk of fall-related hip fractures: a population-based case-control study. Age Ageing 35: 491\u2013497","journal-title":"Age Ageing"},{"key":"1934_CR125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.blo.0000200238.29931.1f","volume":"443","author":"Pennisi","year":"2006","unstructured":"Pennisi P, Trombetti A, Rizzoli R (2006) Glucocorticoid-induced osteoporosis and its treatment. Clin Orthop 443: 39\u201347","journal-title":"Clin Orthop"},{"key":"1934_CR126","doi-asserted-by":"crossref","first-page":"1725S","DOI":"10.1093\/ajcn\/80.6.1725S","volume":"80","author":"Pettifor","year":"2004","unstructured":"Pettifor JM (2004) Nutritional rickets: deficiency of vitamin D, calcium, or both? Am J Clin Nutr 80: 1725S\u20131729S","journal-title":"Am J Clin Nutr"},{"key":"1934_CR127","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s001980200012","volume":"13","author":"Pfeifer","year":"2002","unstructured":"Pfeifer M, Begerow B, Minne HW (2002) Vitamin D and muscle function. Osteoporos Int 13: 187\u2013194","journal-title":"Osteoporos Int"},{"key":"1934_CR128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-2001-14831","volume":"109","author":"Pfeifer","year":"2001","unstructured":"Pfeifer M, Begerow B, Minne HW et al. (2001) Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 109: 87\u201392","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1934_CR129","first-page":"15","volume":"Klin","author":"Pfeifer","year":"2006","unstructured":"Pfeifer M, Minne HW (2006) The role of vitamin d in the treatment of osteoporosis in the elderly. Med Klin (Suppl) 101: 15\u201319","journal-title":"Med"},{"key":"1934_CR130","first-page":"611","volume":"114","author":"Pfeilschifter","year":"2006","unstructured":"Pfeilschifter J (2006) 2006 DVO-guideline for prevention, diagnosis, and therapy of osteoporosis for women after menopause, for men after age 60 executive summary guidelines. Exp Clin Endocrinol Diabetes 114: 611\u2013622","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1934_CR131","unstructured":"Pfeilschifter J (2005) Postmenopausal and steroid-induced osteoporosis guideline-orientated prevention and treatment. Internist (Berl) (Suppl 1) 46: S31\u2013S37"},{"key":"1934_CR132","first-page":"42","volume":"145","author":"Pfeilschifter","year":"2003","unstructured":"Pfeilschifter J, Pientka L, Scheidt-Nave C (2003) Osteoporosis in Germany, 2003 \u2013 a stock taking. MMW Fortschr Med 145: 42\u201343","journal-title":"MMW Fortschr Med"},{"key":"1934_CR133","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00103-004-0839-y","volume":"47","author":"Pientka","year":"2004","unstructured":"Pientka L (2004) Hip fractures (osteoporosis) and geriatric rehabilitation. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 47: 547\u2013553","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"1934_CR134","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s003910050124","volume":"32","author":"Pientka","year":"1999","unstructured":"Pientka L, Friedrich C (1999) The costs of hip-fracture in Germany: a prospective evaluation. Z Gerontol Geriatr 32: 326\u2013332","journal-title":"Z Gerontol Geriatr"},{"key":"1934_CR135","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa020028","volume":"347","author":"Prie","year":"2002","unstructured":"Prie D, Huart V, Bakouh N et al. (2002) Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 347: 983\u2013991","journal-title":"N Engl J Med"},{"key":"1934_CR136","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJMcp042092","volume":"353","author":"Raisz","year":"2005","unstructured":"Raisz LG (2005) Clinical practice. Screening for osteoporosis. N Engl J Med 353: 164\u2013171","journal-title":"N Engl J Med"},{"key":"1934_CR137","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.berh.2004.11.008","volume":"19","author":"Ralston","year":"2005","unstructured":"Ralston SH (2005) Bone densitometry and bone biopsy. Best Pract Res Clin Rheumatol 19: 487\u2013501","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1934_CR138","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1101\/gad.1449506","volume":"20","author":"Ralston","year":"2006","unstructured":"Ralston SH, Crombrugghe B de (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20: 2492\u20132506","journal-title":"Genes Dev"},{"key":"1934_CR139","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.blo.0000200234.99436.24","volume":"443","author":"Reginster","year":"2006","unstructured":"Reginster JY, Devogelaer JP (2006) Raloxifene reduces fractures in postmenopausal women with osteoporosis. Clin Orthop 443: 48\u201354","journal-title":"Clin Orthop"},{"key":"1934_CR140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9343(00)00510-6","volume":"109","author":"Reid","year":"2000","unstructured":"Reid IR, Ames RW, Orr-Walker BJ et al. (2000) Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 109: 362\u2013370","journal-title":"Am J Med"},{"key":"1934_CR141","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00198-006-0200-4","volume":"17","author":"Rhee","year":"2006","unstructured":"Rhee Y, Kang M, Min Y et al. (2006) Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Osteoporos Int 17: 1801\u20131807","journal-title":"Osteoporos Int"},{"key":"1934_CR142","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS et al. (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112: 683\u2013692","journal-title":"J Clin Invest"},{"key":"1934_CR143","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00296-006-0288-z","volume":"27","author":"Ringe","year":"2007","unstructured":"Ringe JD, Farahmand P, Schacht E, Rozehnal A (2007) Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial). Rheumatol Int 27: 425\u2013434","journal-title":"Rheumatol Int"},{"key":"1934_CR144","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1521-690X(03)00055-1","volume":"17","author":"Ritz","year":"2003","unstructured":"Ritz E, Haxsen V, Zeier M (2003) Disorders of phosphate metabolism\u2013pathomechanisms and management of hypophosphataemic disorders. Best Pract Res Clin Endocrinol Metab 17: 547\u2013558","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1934_CR145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMcp043801","volume":"353","author":"Rosen","year":"2005","unstructured":"Rosen CJ (2005) Clinical practice. Postmenopausal osteoporosis. N Engl J Med 353: 595\u2013603","journal-title":"N Engl J Med"},{"key":"1934_CR146","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ncprheum0070","volume":"2","author":"Rosen","year":"2006","unstructured":"Rosen CJ, Bouxsein ML (2006) Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2: 35\u201343","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1934_CR147","first-page":"167","volume":"6","author":"Runge","year":"2006","unstructured":"Runge M, Hunter G (2006) Determinants of musculoskeletal frailty and the risk of falls in old age. J Musculoskelet Neuronal Interact 6: 167\u2013173","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"1934_CR148","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1196\/annals.1346.041","volume":"1068","author":"Russell","year":"2006","unstructured":"Russell RG (2006) Bisphosphonates: from bench to bedside. Ann N Y Acad Sci 1068: 367\u2013401","journal-title":"Ann N Y Acad Sci"},{"key":"1934_CR149","first-page":"9","volume":"Urol","author":"Saad","year":"2005","unstructured":"Saad F, Perrotte P, Benard F et al. (2005) Bone health in men with prostate cancer: diagnostic and therapeutic considerations. Can J Urol (Suppl 2) 12: 9\u201315","journal-title":"Can J"},{"key":"1934_CR150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00776-006-1057-2","volume":"11","author":"Sakamoto","year":"2006","unstructured":"Sakamoto K, Nakamura T, Hagino H et al. (2006) Effects of unipedal standing balance exercise on the prevention of falls and hip fracture among clinically defined high-risk elderly individuals: a randomized controlled trial. J Orthop Sci 11: 467\u2013472","journal-title":"J Orthop Sci"},{"key":"1934_CR151","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","volume":"367","author":"Sambrook","year":"2006","unstructured":"Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367: 2010\u20132018","journal-title":"Lancet"},{"key":"1934_CR152","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1055\/s-2003-38848","volume":"128","author":"Scharla","year":"2003","unstructured":"Scharla S (2003) Causes of osteoporosis: don\u2019t forget celiac disease. Dtsch Med Wochenschr 128: 916\u2013919","journal-title":"Dtsch Med Wochenschr"},{"key":"1934_CR153","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1055\/s-0029-1232564","volume":"107","author":"Scharla","year":"1999","unstructured":"Scharla SH, Wolf S, Dull R, Lempert UG (1999) Prevalence of low bone mass and endocrine disorders in hip fracture patients in Southern Germany. Exp Clin Endocrinol Diabetes 107: 547\u2013554","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1934_CR154","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJM200301163480319","volume":"348","author":"Scheinman","year":"2003","unstructured":"Scheinman SJ, Tenenhouse HS (2003) Nephrolithiasis, osteoporosis, and mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 348: 264\u2013265; author reply 264\u2013265","journal-title":"N Engl J Med"},{"key":"1934_CR155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00198-005-2010-5","volume":"17","author":"Schousboe","year":"2006","unstructured":"Schousboe JT, Debold CR (2006) Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos Int 17: 281\u2013289","journal-title":"Osteoporos Int"},{"key":"1934_CR156","first-page":"354","volume":"58","author":"Schulz","year":"1974","unstructured":"Schulz A, Delling G (1974) Comparative histologic and morphometric studies of rickety bone disorders (author\u2019s transl). Verh Dtsch Ges Pathol 58: 354\u2013359","journal-title":"Verh Dtsch Ges Pathol"},{"key":"1934_CR157","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1055\/s-2003-40935","volume":"128","author":"Schutze","year":"2003","unstructured":"Schutze N, Ebert R, Paunescu K, Jakob F (2003) Genetics of osteoporosis. Dtsch Med Wochenschr 128: 1609\u20131614","journal-title":"Dtsch Med Wochenschr"},{"key":"1934_CR158","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11914-996-0015-4","volume":"3","author":"Schwartz","year":"2005","unstructured":"Schwartz EN, Steinberg D (2005) Detection of vertebral fractures. Curr Osteoporos Rep 3: 126\u2013135","journal-title":"Curr Osteoporos Rep"},{"key":"1934_CR159","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jc.2006-0857","volume":"92","author":"Scillitani","year":"2007","unstructured":"Scillitani A, Guarnieri V, Battista C et al. (2007) Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. J Clin Endocrinol Metab 92: 277\u2013283","journal-title":"J Clin Endocrinol Metab"},{"key":"1934_CR160","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJM199406233302502","volume":"330","author":"Sebastian","year":"1994","unstructured":"Sebastian A, Harris ST, Ottaway JH et al. (1994) Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med 330: 1776\u20131781","journal-title":"N Engl J Med"},{"key":"1934_CR161","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5694\/j.1326-5377.2004.tb05931.x","volume":"180","author":"Seeman","year":"2004","unstructured":"Seeman E, Eisman JA (2004) 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual\u2019s absolute risk of fracture. Med J Aust 180: 298\u2013303","journal-title":"Med J Aust"},{"key":"1934_CR162","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","volume":"345","author":"Seufert","year":"2001","unstructured":"Seufert J, Ebert K, Muller J et al. (2001) Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345: 1883\u20131888","journal-title":"N Engl J Med"},{"key":"1934_CR163","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s00268-004-7562-6","volume":"28","author":"Sitges-Serra","year":"2004","unstructured":"Sitges-Serra A, Girvent M, Pereira JA et al. (2004) Bone mineral density in menopausal women with primary hyperparathyroidism before and after parathyroidectomy. World J Surg 28: 1148\u20131152","journal-title":"World J Surg"},{"key":"1934_CR164","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00113-005-0972-6","volume":"108","author":"Smektala","year":"2005","unstructured":"Smektala R, Ohmann C, Paech S et al. (2005) On the prognosis of hip fractures. Assessment of mortality after hip fractures by analyzing overlapping segments of longitudinal data. Unfallchirurg 108: 927\u2013928, 930\u2013937","journal-title":"Unfallchirurg"},{"key":"1934_CR165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.csm.2005.08.009","volume":"25","author":"Sofka","year":"2006","unstructured":"Sofka CM (2006) Imaging of stress fractures. Clin Sports Med 25: 53\u201362, viii","journal-title":"Clin Sports Med"},{"key":"1934_CR166","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00198-006-0226-7","volume":"18","author":"Stenvall","year":"2007","unstructured":"Stenvall M, Olofsson B, Lundstrom M et al. (2007) A multidisciplinary, multifactorial intervention program reduces postoperative falls and injuries after femoral neck fracture. Osteoporos Int 18: 167\u2013175","journal-title":"Osteoporos Int"},{"key":"1934_CR167","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF03327422","volume":"18","author":"Suominen","year":"2006","unstructured":"Suominen H (2006) Muscle training for bone strength. Aging Clin Exp Res 18: 85\u201393","journal-title":"Aging Clin Exp Res"},{"key":"1934_CR168","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1359\/jbmr.1997.12.2.255","volume":"12","author":"Taaffe","year":"1997","unstructured":"Taaffe DR, Robinson TL, Snow CM, Marcus R (1997) High-impact exercise promotes bone gain in well-trained female athletes. J Bone Miner Res 12: 255\u2013260","journal-title":"J Bone Miner Res"},{"key":"1934_CR169","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1359\/JBMR.051023","volume":"21","author":"Tashjian","year":"2006","unstructured":"Tashjian AH Jr, Gagel RF (2006) Teriparatide [human PTH(1\u201334)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis. J Bone Miner Res 21: 354\u2013365","journal-title":"J Bone Miner Res"},{"key":"1934_CR170","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4158\/EP.12.5.559","volume":"12","author":"Taylor","year":"2006","unstructured":"Taylor HC, Elbadawy EH (2006) Renal tubular acidosis type 2 with Fanconi\u2019s syndrome, osteomalacia, osteoporosis, and secondary hyperaldosteronism in an adult consequent to vitamin D and calcium deficiency: effect of vitamin D and calcium citrate therapy. Endocr Pract 12: 559\u2013567","journal-title":"Endocr Pract"},{"key":"1934_CR171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/146532806X90556","volume":"26","author":"Thacher","year":"2006","unstructured":"Thacher TD, Fischer PR, Strand MA, Pettifor JM (2006) Nutritional rickets around the world: causes and future directions. Ann Trop Paediatr 26: 1\u201316","journal-title":"Ann Trop Paediatr"},{"key":"1934_CR172","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.3816\/CBC.2005.s.006","volume":"Cancer","author":"Theriault","year":"2005","unstructured":"Theriault RL (2005) Strategies to prevent chemotherapy-induced bone loss in women with breast cancer. Clin Breast Cancer (Suppl) 5: S63\u2013S70","journal-title":"Clin Breast"},{"key":"1934_CR173","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00393-005-0719-3","volume":"64","author":"Thiele","year":"2005","unstructured":"Thiele K, Buttgereit F, Huscher D, Zink A (2005) Prescription of glucocorticoids by rheumatologists in patients with rheumatoid arthritis in Germany. Z Rheumatol 64: 149\u2013154","journal-title":"Z Rheumatol"},{"key":"1934_CR174","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","volume":"338","author":"Thomas","year":"1998","unstructured":"Thomas MK, Lloyd-Jones DM, Thadhani RI et al. (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338: 777\u2013783","journal-title":"N Engl J Med"},{"key":"1934_CR175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00198-006-0204-0","volume":"18","author":"Vestergaard","year":"2007","unstructured":"Vestergaard P, Jorgensen NR, Mosekilde L, Schwarz P (2007) Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk\u2013a meta-analysis. Osteoporos Int 18: 45\u201357","journal-title":"Osteoporos Int"},{"key":"1934_CR176","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00132-006-0949-3","volume":"35","author":"Welsch","year":"2006","unstructured":"Welsch M, Welsch F, Grunwald F (2006) Nuclear medicine techniques in the diagnosis of orthopaedic diseases. Orthopade 35: 632\u2013640, 642\u2013633","journal-title":"Orthopade"},{"key":"1934_CR177","first-page":"349","volume":"7","author":"Whitfield","year":"2006","unstructured":"Whitfield JF (2006) Osteoporosis-treating parathyroid hormone peptides: What are they? What do they do? How might they do it? Curr Opin Investig Drugs 7: 349\u2013359","journal-title":"Curr Opin Investig Drugs"},{"key":"1934_CR178","first-page":"27","volume":"6","author":"Williams","year":"2006","unstructured":"Williams FM, Spector TD (2006) Recent advances in the genetics of osteoporosis. J Musculoskelet Neuronal Interact 6: 27\u201335","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"1934_CR179","first-page":"68","volume":"83","author":"Woitge","year":"1998","unstructured":"Woitge HW, Scheidt-Nave C, Kissling C et al. (1998) Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. J Clin Endocrinol Metab 83: 68\u201375","journal-title":"J Clin Endocrinol Metab"},{"key":"1934_CR180","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00774-004-0589-9","volume":"23","author":"Yamamoto","year":"2005","unstructured":"Yamamoto T, Imanishi Y, Kinoshita E et al. (2005) The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome. J Bone Miner Metab 23: 231\u2013237","journal-title":"J Bone Miner Metab"},{"key":"1934_CR181","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2741\/2252","volume":"12","author":"Zhao","year":"2007","unstructured":"Zhao Q, Shao J, Chen W, Li YP (2007) Osteoclast differentiation and gene regulation. Front Biosci 12: 2519\u20132529","journal-title":"Front Biosci"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1934-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-007-1934-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1934-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T16:41:10Z","timestamp":1629736870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-007-1934-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,20]]},"references-count":181,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["1934"],"URL":"https:\/\/doi.org\/10.1007\/s00108-007-1934-6","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,20]]}}}